GlassScriptPhysician profile
Seyed M Hashemi
NPI 1831186790
$14,812.06
in general payments reported to CMS, 2019-2025
38 companies · $1,304 in 2025
The $1,304 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,322 · 2020: $1,183 · 2021: $882 · 2022: $1,755 · 2023: $1,406 · 2024: $1,959 · 2025: $1,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,571 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,570.75 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $6,103.84 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,122.60 | 2021-2025 | |
| Novo Nordisk INC | $1,012.01 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Actelion Pharmaceuticals US, INC. | $872.54 | 2019-2025 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $718.53 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $680.56 | 2019-2025 | Farxiga |
| Boston Scientific Corporation | $480.91 | 2019-2025 | Watchman Access System |
| Merck Sharp & Dohme LLC | $473.10 | 2021-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $450.26 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $437.13 | 2019-2025 | Jardiance |
| Amgen INC. | $333.29 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $280.51 | 2022-2025 | Eliquis, Camzyos |
| Qorumpartners | $257.37 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $174.31 | 2019-2024 | Lifevest |
| Esperion Therapeutics, INC. | $170.60 | 2020-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicomp INC | $144.60 | 2023-2024 | Telepatch Cardiac Monitor |
| Amarin Pharma, INC. | $118.06 | 2020-2022 | |
| Abiomed | $103.55 | 2019-2025 | |
| Itamar Medical INC | $97.20 | 2023 | Watchpatone |
| Coala Life INC | $90.58 | 2022 | |
| Philips North America LLC | $89.28 | 2022-2025 | Peripheral Vascular Undivided, (Ck7) Extended Holter |
| Scpharmaceuticals INC. | $81.34 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $74.65 | 2023-2024 | Inpefa |
| Atricure, INC. | $61.78 | 2022-2023 | |
| Abbott Laboratories | $59.70 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Kiniksa Pharmaceuticals, LTD. | $42.30 | 2021-2022 | |
| Astellas Pharma US INC | $35.64 | 2019-2020 | |
| Lundbeck LLC | $35.01 | 2020-2021 | |
| Cvrx, INC. | $29.96 | 2024 | Barostim Neo System |
| Baxter Healthcare | $27.34 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $27.18 | 2019 | |
| Lilly USA, LLC | $21.72 | 2025 | Zepbound |
| Heartflow, INC. | $21.01 | 2025 | |
| Irhythm Technologies, INC. | $20.24 | 2022 | |
| United Therapeutics Corporation | $18.41 | 2024 | Tyvaso |
| Arbor Pharmaceuticals, INC. | $17.21 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $15.27 | 2024 | Rhythm Express |
| Bardy Diagnostics, INC. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seyed Hashemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.